Emily Dressler to Breast Neoplasms
This is a "connection" page, showing publications Emily Dressler has written about Breast Neoplasms.
Connection Strength
0.277
-
Massarweh S, Romond E, Black EP, Van Meter E, Shelton B, Kadamyan-Melkumian V, Stevens M, Elledge R. A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure. Breast Cancer Res Treat. 2014 Jan; 143(2):325-32.
Score: 0.153
-
Patel R, Maxwell S, Yan D, Dressler EV, Romond EH, Mathew A. Medical oncologists' perception of antiestrogen therapy benefit in premenopausal women with hormone receptor-positive early-stage breast cancer. Ann Oncol. 2018 03 01; 29(3):772-773.
Score: 0.103
-
Hayslip J, Dressler EV, Weiss H, Taylor TJ, Chambers M, Noel T, Miriyala S, Keeney JT, Ren X, Sultana R, Vore M, Butterfield DA, St Clair D, Moscow JA. Plasma TNF-a and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical Study. PLoS One. 2015; 10(4):e0124988.
Score: 0.021